Individuals identified as being at higher risk should be advised about appropriate methods of sun protection, educated about the diagnostic features of cutaneous melanoma and encouraged to perform self examination of the skin.
Risk factor |
OR* |
Information |
11–50 common moles >2 mm |
1.7 to 1.9 |
The risk of melanoma rises with the number of common moles. |
51–100 common moles >2 mm |
3.2 to 3.7 |
|
>100 common moles >2 mm |
7.6 to 7.7 |
|
Family history of melanoma |
1.8 |
Melanoma in a first degree family member (parent, sibling or child of the patient). |
Previous history of melanoma |
|
Standardised incidence ratio range 4.5 to 25.6 |
The presence of 1–4 atypical moles |
1.6 to 7.3 |
Atypical moles: ill-defined or irregular border; irregular pigmentation; diameter >5 mm; erythema (blanchable in lesion or at edge); accentuated skin markings. |
Red or light-coloured hair |
1.4 to 3.5 |
|
Presence of actinic lentigines |
1.9 to 3.5 |
Actinic lentigines: flat, brown skin lesions associated with acute and chronic sun exposure. No direct malignant potential. |
Giant congenital melanocytic naevi ≥20 cm in diameter |
|
Relative risk range 239 to 1,224 for extracutaneous as well as cutaneous melanoma. |
Unusually high sun exposure |
2.6 |
|
Reported growth of a mole |
2.3 |
|
Skin that does not tan easily |
1.98 |
|
Light-coloured eyes |
1.55 to 1.60 |
|
Light-coloured skin |
1.40 to 1.42 |
|
Affluence |
|
Relative risk approximately 3.0 for people residing in areas defined as Carstairs deprivation category 1 (least deprived) compared to Carstairs category 7 (most deprived). |
Age |
|
Melanoma is rare in absolute terms in childhood and adolescence. Risk begins to increase with age during adolescence, the elderly being at highest risk. The validity of some risk factors, such as hair colour and sun exposure, is lower in the elderly. |
*OR = odds ratio. In some cases the range of ORs from more than a single study are given.
For example: a person with skin that does not tan easily has an approximately two-fold (1.98 times) risk of developing melanoma compared to someone with skin that tans (after allowing for other risk factors). This is modest in comparison, for example, to the approximately 10-fold or greater risk of developing lung cancer in someone who smokes cigarettes compared to a person who has never smoked.
All patients with melanoma and a history of immunosuppression should have a multidisciplinary team approach to care. Minimising the immunosuppressive therapy should be considered where possible.